VITABOL VITAMIN C

This brand name is authorized in Nigeria.

Active ingredients

The drug VITABOL VITAMIN C contains one active pharmaceutical ingredient (API):

1	Vitamin C UNII PQ6CK8PD0R - ASCORBIC ACID
	Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.
	Read more about Vitamin C

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2805	Chewable tablet	Vitabol Chewable Vitamin C Tablet TAB_CHEW 100 mg	Chewable Tablet	27/08/2021
A11-100533	Syrup	VITABOL VITAMIN C SYRUP SYRUP 100 mg/5 mL 1x100ML	VITABOL VITAMIN C SYRUP ASCORBIC ACID Ascorbic Acid 100mg, Methyl Paraben 4.6mg, Propyl Paraben 0.525mg, Sodium Hydroxide Pellets 30mg, Granulated Sugar 3.2g, Propylene Glycol 255mg, Glycerol 245mg, Sodium Metabisulphite 10mg, Flavour Orange 0.005ml, Colour Riboflavin Phosphate 0.25mg, Citric Acid Monohydrate Solution 50%w/v, Demineralised Water (Purified Water) 5ml. Drugs VARIOUS Nigerian Products 1010packs100mg Over The Counter (OTC) 23/03/2023 EFUNPO PHARM LIMITED, , EDUN STREET LADIPO LAGOS 8060422619 hello@efunpopharma.com DAILY NEED INDUSTRY LIMITED, PLOT 9/10 DAILY NEED LANE, OFF LADIPO MARKET, MATORI, MUSHIN, LAGOS, Nigeria	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A11GA01	Ascorbic acid (vit C)	A Alimentary tract and metabolism → A11 Vitamins → A11G Ascorbic acid (Vitamin C), incl. combinations → A11GA Ascorbic acid (vitamin C), plain
Discover more medicines within A11GA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-2805, A11-100533